Inventor
LANDI ABDOLAMIR
CA15 patents
⚠️ This page may combine multiple inventors who share the name “LANDI ABDOLAMIR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV ALBERTA
14 patentsUS10300131B2May 28, 2019
Hepatitis C virus immunogenic compositions and methods of use thereof
UNIV ALBERTA4 citations82
US11324818B2May 10, 2022
Hepatitis c virus immunogenic compositions and methods of use thereof
UNIV ALBERTA2 citations71
US9535071B2Jan 3, 2017
Methods and compositions for diagnosis of inflammatory liver disease
UNIV ALBERTA2 citations68
US12296005B2May 13, 2025
Hepatitis C virus immunogenic compositions and methods of use thereof
UNIV ALBERTA0 citations61
US12005116B2Jun 11, 2024
Hepatitis C virus immunogenic compositions and methods of use thereof
UNIV ALBERTA0 citations61
US11576967B2Feb 14, 2023
Hepatitis C virus immunogenic compositions and methods of use thereof
UNIV ALBERTA0 citations61
US10881727B2Jan 5, 2021
Hepatitis C virus immunogenic compositions and methods of use thereof
UNIV ALBERTA0 citations61
US12042536B2Jul 23, 2024
Hepatitis C virus immunogenic compositions and methods of use thereof
UNIV ALBERTA0 citations60
US11576968B2Feb 14, 2023
Hepatitis C virus immunogenic compositions and methods of use thereof
UNIV ALBERTA0 citations60
US10881726B2Jan 5, 2021
Hepatitis C virus immunogenic compositions and methods of use thereof
UNIV ALBERTA0 citations60
US12048742B2Jul 30, 2024
Hepatitis C virus peptide compositions and methods of use thereof
UNIV ALBERTA0 citations50
US10408844B2Sep 10, 2019
Methods and compositions in diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis
UNIV ALBERTA0 citations48
US10641780B2May 5, 2020
Methods and compositions for treatment of autoimmune hepatitis
UNIV ALBERTA0 citations47
US9952226B2Apr 24, 2018
Methods of treatment of primary sclerosing cholangitis
UNIV ALBERTA0 citations47